Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2024-11-28
DOI
https://doi.org/10.3324/haematol.2024.286257
Citations
6
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Antonio Salar, Monica Tani, Joshua Brody, Guillaume Cartron et al.
6 citations
Haematologica
Lymphoma Diagnosis and Treatment
2.55
article

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Antonio Salar, Monica Tani, Joshua Brody, Guillaume Cartron, Joaquín Martínez‐López, Carmelo Carlo‐Stella, Aurelien Berthier, Franck Morschhauser, Sirpa Leppä, Emmanuel Bachy, Martine Kallemeijn, Fabiola Bene Tchaleu, Martin Hutchings, Linda Lundberg, James Relf, Nancy L. Bartlett, Lorenzo Falchi, Michael John Dickinson, Cyrus Khan
article en
6 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(4)
Roche (Switzerland) (CH), University of Copenhagen (DK), Allegheny Health Network (US), The Royal Melbourne Hospital (AU), Memorial Sloan Kettering Cancer Center (US), University of Helsinki (FI), Humanitas University (IT), The University of Melbourne (AU), Washington University in St. Louis (US), Helsinki University Hospital (FI), Peter MacCallum Cancer Centre (AU), Rigshospitalet (DK), Ospedale "Santa Maria delle Croci" di Ravenna (IT), Centre Hospitalier Universitaire de Montpellier (FR), Hospices Civils de Lyon (FR), Roche (United Kingdom) (GB), Tisch Hospital (US), Hospital Del Mar (ES), Centro de Investigación del Cáncer (ES), Hôpital Claude Huriez (FR), IRCCS Humanitas Research Hospital (IT), Tisch Cancer Institute
F. Hoffmann-La Roche
Good health and well-being
Openalex Percentile: Top 10%
Lymphoma Diagnosis and Treatment
2.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.